These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16754809)

  • 1. Viewpoint: Sir Richard Sykes, DSc, FRS, FMedSci. Interview by Ingrid Torjesen, BSc.
    Sykes R
    Circulation; 2006 Jun; 113(22):f85-6. PubMed ID: 16754809
    [No Abstract]   [Full Text] [Related]  

  • 2. The special treatment.
    Osborne R
    Nat Biotechnol; 2008 May; 26(5):487-9. PubMed ID: 18464770
    [No Abstract]   [Full Text] [Related]  

  • 3. Tysabri's troubles return.
    Hoag H
    Nat Biotechnol; 2008 Oct; 26(10):1061. PubMed ID: 18846062
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug regulation 2056.
    Bezold C; Peck J
    Food Drug Law J; 2005; 60(2):127-36. PubMed ID: 16097091
    [No Abstract]   [Full Text] [Related]  

  • 5. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 6. Industry looks to buck bias in emerging 'adaptive' designs.
    Torres C
    Nat Med; 2010 Jun; 16(6):619. PubMed ID: 20526301
    [No Abstract]   [Full Text] [Related]  

  • 7. First Chinese-made biologics slated for human trials in the West.
    Deng B
    Nat Med; 2014 Jun; 20(6):562. PubMed ID: 24901550
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical setbacks for toll-like receptor 9 agonists in cancer.
    Schmidt C
    Nat Biotechnol; 2007 Aug; 25(8):825-6. PubMed ID: 17687345
    [No Abstract]   [Full Text] [Related]  

  • 9. Trading on traditional medicines.
    Basu P
    Nat Biotechnol; 2004 Mar; 22(3):263-5. PubMed ID: 14990941
    [No Abstract]   [Full Text] [Related]  

  • 10. Moment of reckoning.
    Wadman M
    Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug development research: diabetes favored over cardiovascular disease?
    Suckling K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):217-9. PubMed ID: 19333877
    [No Abstract]   [Full Text] [Related]  

  • 12. Tysabri back on market.
    Sheridan C
    Nat Biotechnol; 2006 Aug; 24(8):874. PubMed ID: 16900111
    [No Abstract]   [Full Text] [Related]  

  • 13. Trouble at the office.
    Allison M
    Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
    [No Abstract]   [Full Text] [Related]  

  • 14. Small study on industry trial sponsorship leads to big questions about quality and bias.
    Twombly R
    J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
    [No Abstract]   [Full Text] [Related]  

  • 15. Russian drug law hinders clinical trials.
    Katsnelson A
    Nature; 2012 Jan; 481(7381):250. PubMed ID: 22258585
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant protein therapeutics--success rates, market trends and values to 2010.
    Pavlou AK; Reichert JM
    Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
    [No Abstract]   [Full Text] [Related]  

  • 17. Market watch: upcoming market catalysts in Q3 2012.
    Jeng R
    Nat Rev Drug Discov; 2012 Jun; 11(7):508. PubMed ID: 22743969
    [No Abstract]   [Full Text] [Related]  

  • 18. More bad news about money and medical science.
    Fielder JH
    IEEE Eng Med Biol Mag; 2003; 22(2):102-3. PubMed ID: 12733466
    [No Abstract]   [Full Text] [Related]  

  • 19. [Introduction: "The scope of this forum" and "the necessity of introduction of compassionate use system in Japan"].
    Fujiwara Y
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):281-3. PubMed ID: 17301543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prozac papers.
    New Sci; 2005 Jan 8-14; 185(2481):4. PubMed ID: 15812956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.